P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Update

P3 Health Partners Inc. (NASDAQ:PIII) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 15,836 shares, a decrease of 35.9% from the December 31st total of 24,688 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily trading volume, of 13,081 shares, the days-to-cover ratio is currently 1.2 days. Based on an average daily trading volume, of 13,081 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.3% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on PIII shares. Lake Street Capital lowered their price target on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating for the company in a report on Monday, November 17th. BTIG Research reissued a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.50.

Institutional Investors Weigh In On P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC boosted its stake in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,678 shares of the company’s stock after buying an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned 0.37% of P3 Health Partners worth $239,000 at the end of the most recent quarter. 7.75% of the stock is currently owned by institutional investors.

P3 Health Partners Stock Performance

NASDAQ PIII traded down $0.13 on Friday, hitting $1.92. The stock had a trading volume of 71,066 shares, compared to its average volume of 18,113. The company’s 50-day moving average is $3.94 and its two-hundred day moving average is $6.55. P3 Health Partners has a one year low of $1.61 and a one year high of $12.44. The stock has a market cap of $13.84 million, a price-to-earnings ratio of -0.05 and a beta of 0.90. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($9.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). The business had revenue of $345.25 million during the quarter, compared to the consensus estimate of $346.64 million. P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 9.07%. On average, analysts expect that P3 Health Partners will post -0.67 earnings per share for the current year.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.